| Name | Goodrich Pharmacy |
|---|---|
| Organization Name | Goodrich Pharmacy Inc |
| Location | 601 Jacob Ln, Anoka, Minnesota 55303 |
| Type | Pharmacy |
| Phone | (763) 421-5540 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Battery manufacturer Accutronics is making available for download its latest whitepaper, which tackles the issues facing battery design, development and use in the medical and healthcare field.
A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.
Risks of SARS-CoV-2 coronavirus infection for long-stay nursing home residents were mainly dependent on factors in their nursing homes and surrounding communities, according to a large study led by a researcher at the Johns Hopkins Bloomberg School of Public Health.
Accellent Inc. (the "Company"), a wholly owned subsidiary of Accellent Holdings Corp. ("Accellent"), today announced certain preliminary financial information for its fiscal fourth quarter and the full year ended December 31, 2009.
CHD5 has previously been proposed as a tumour suppressor, acting as a brake that prevents healthy cells from developing into cancer cells. But the part played by the protein in healthy tissue, and whether this role is important for its ability to counter tumour growth, has remained largely uncharted.
› Verified 2 days ago
| NPI Number | 1346244274 |
| Organization Name | GOODRICH PHARMACY INC |
| Doing Business As | GOODRICH PHARMACY INC |
| Type | Pharmacy |
| Address | 2621 Greenhaven Rd Ste 1, Anoka, MN 55303 |
| Phone Number | 763-421-5540 |
News Archive
Battery manufacturer Accutronics is making available for download its latest whitepaper, which tackles the issues facing battery design, development and use in the medical and healthcare field.
A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.
Risks of SARS-CoV-2 coronavirus infection for long-stay nursing home residents were mainly dependent on factors in their nursing homes and surrounding communities, according to a large study led by a researcher at the Johns Hopkins Bloomberg School of Public Health.
Accellent Inc. (the "Company"), a wholly owned subsidiary of Accellent Holdings Corp. ("Accellent"), today announced certain preliminary financial information for its fiscal fourth quarter and the full year ended December 31, 2009.
CHD5 has previously been proposed as a tumour suppressor, acting as a brake that prevents healthy cells from developing into cancer cells. But the part played by the protein in healthy tissue, and whether this role is important for its ability to counter tumour growth, has remained largely uncharted.
› Verified 2 days ago
| NPI Number | 1457937773 |
| Organization Name | GOODRICH PHARMACY, INC. |
| Doing Business As | GOODRICH PHARMACY LTC |
| Type | Long Term Care Pharmacy |
| Address | 2321 7th Ave, Anoka, MN 55303 |
| Phone Number | 763-421-5540 |
News Archive
Battery manufacturer Accutronics is making available for download its latest whitepaper, which tackles the issues facing battery design, development and use in the medical and healthcare field.
A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.
Risks of SARS-CoV-2 coronavirus infection for long-stay nursing home residents were mainly dependent on factors in their nursing homes and surrounding communities, according to a large study led by a researcher at the Johns Hopkins Bloomberg School of Public Health.
Accellent Inc. (the "Company"), a wholly owned subsidiary of Accellent Holdings Corp. ("Accellent"), today announced certain preliminary financial information for its fiscal fourth quarter and the full year ended December 31, 2009.
CHD5 has previously been proposed as a tumour suppressor, acting as a brake that prevents healthy cells from developing into cancer cells. But the part played by the protein in healthy tissue, and whether this role is important for its ability to counter tumour growth, has remained largely uncharted.
› Verified 2 days ago
News Archive
Battery manufacturer Accutronics is making available for download its latest whitepaper, which tackles the issues facing battery design, development and use in the medical and healthcare field.
A multicenter EPIC (FiberNet- Embolic Protection System in Carotid Artery Stenting Trial) study found that the FiberNet Embolic Protection System (EPS) had a 97.5% success rate when used in patients undergoing carotid artery stenting (CAS). Full findings are published early online in Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions.
Risks of SARS-CoV-2 coronavirus infection for long-stay nursing home residents were mainly dependent on factors in their nursing homes and surrounding communities, according to a large study led by a researcher at the Johns Hopkins Bloomberg School of Public Health.
Accellent Inc. (the "Company"), a wholly owned subsidiary of Accellent Holdings Corp. ("Accellent"), today announced certain preliminary financial information for its fiscal fourth quarter and the full year ended December 31, 2009.
CHD5 has previously been proposed as a tumour suppressor, acting as a brake that prevents healthy cells from developing into cancer cells. But the part played by the protein in healthy tissue, and whether this role is important for its ability to counter tumour growth, has remained largely uncharted.
› Verified 2 days ago
Cvs Pharmacy #08930 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 657 E Main St, Anoka, Minnesota 55303 Phone: (763) 427-2287 | |
Walgreens #3423 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1911 S Ferry St, Anoka, Minnesota 55303 Phone: (763) 576-0388 | |
Healthpartners Riverway Clinic-anok Type: Medicare Supplier Location: 601 Jacob Ln, Anoka, Minnesota 55303 Phone: (612) 623-4000 | |
Walgreens #11832 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3605 Round Lake Blvd Nw, Anoka, Minnesota 55303 Phone: (763) 252-0751 |